CANCER

IBTimes Logo

Calif. Insurer Won't Pay for Breast Cancer Drug

Health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial.

Fighting halts aid mission into Libyan siege city

Libya
A Red Cross convoy carrying aid to relieve a humanitarian crisis in Libya's besieged city of Sirte had to turn back on Monday because Libyan interim government forces unleashed a barrage of fire.
More news
Tim Cook with the iPhone

Apple iPhone 5 Release Date, Features: 10 Important Things to Know

The Apple Let's talk iPhone event is just two days away, and up-to-the-last minute rumors have been rampant. On Tuesday, we'll have all the facts confirmed about the the Apple iPhone 5 release date and features. CEO Tim Cook will preside for retired company co-founder and long-time leader Steve Jobs. But while speculation is abundant, much has become clear about the Apple iPhone 5 release date and features.
Michael Ovitz, former Disney President arrives at the Sun Valley Resort in Sun Valley, Idaho

IMG board votes to oust Ovitz after failed bid

The advisory board of IMG held a conference call on Friday to discuss what to do about Michael Ovitz's play to take over company management, according to an individual with knowledge of the call.
Cast member Anjelica Huston arrives for the premiere of the film ''50/50'' in New York

Cancer Comedy 50/50 Hits Home for Anjelica Huston

Oscar winning actress Angelica Huston has often played quirky roles in films like The Addams Family and The Royal Tenenbaums. This weekend, the 60 year-old Hollywood star plays her most normal character to date in the cancer comedy 50/50.
IBTimes Logo

Sylvia Robinson, 'Mother of Hip-Hop,' Dies

Sylvia Robinson, best known to be the mastermind behind the Sugarhill Gang’s “Rapper’s Delight,” the first hip-hop single to become a commercial hit, died Thursday at age 75.
IBTimes Logo

Geron Names John Scarlett as CEO

Geron Corp (GERN.O), which is conducting the first U.S.-approved human embryonic stem cell trial, has named John Scarlett as its chief executive officer, replacing interim CEO David Greenwood, who will leave the biotech company at the end of the year.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.